Merchan J - Search Results

1

Targeted delivery of an antibody-mutant human endostatin fusion protein results in enhanced antitumor efficacy.

Shin SU, Cho HM, Merchan J, Zhang J, Kovacs K, Jing Y, Ramakrishnan S, Rosenblatt JD. Shin SU, et al. Among authors: merchan j. Mol Cancer Ther. 2011 Apr;10(4):603-14. doi: 10.1158/1535-7163.MCT-10-0804. Epub 2011 Mar 10. Mol Cancer Ther. 2011. PMID: 21393427

2

Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.

Jing Y, Tong C, Zhang J, Nakamura T, Iankov I, Russell SJ, Merchan JR. Jing Y, et al. Among authors: merchan jr. Cancer Res. 2009 Feb 15;69(4):1459-68. doi: 10.1158/0008-5472.CAN-08-2628. Epub 2009 Feb 10. Cancer Res. 2009. PMID: 19208845 Free PMC article.

3

Antiangiogenic activity of 2-deoxy-D-glucose.

Merchan JR, Kovács K, Railsback JW, Kurtoglu M, Jing Y, Piña Y, Gao N, Murray TG, Lehrman MA, Lampidis TJ. Merchan JR, et al. PLoS One. 2010 Oct 27;5(10):e13699. doi: 10.1371/journal.pone.0013699. PLoS One. 2010. PMID: 21060881 Free PMC article.

4

Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects.

Jing Y, Kovacs K, Kurisetty V, Jiang Z, Tsinoremas N, Merchan JR. Jing Y, et al. Mol Cancer Res. 2012 Oct;10(10):1271-81. doi: 10.1158/1541-7786.MCR-12-0145. Epub 2012 Aug 21. Mol Cancer Res. 2012. PMID: 22912336 Free PMC article.

5

In vivo safety, biodistribution and antitumor effects of uPAR retargeted oncolytic measles virus in syngeneic cancer models.

Jing Y, Zaias J, Duncan R, Russell SJ, Merchan JR. Jing Y, et al. Among authors: merchan jr. Gene Ther. 2014 Mar;21(3):289-97. doi: 10.1038/gt.2013.84. Epub 2014 Jan 16. Gene Ther. 2014. PMID: 24430235 Free PMC article.

6

In vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer.

Jing Y, Bejarano MT, Zaias J, Merchan JR. Jing Y, et al. Among authors: merchan jr. Breast Cancer Res Treat. 2015 Jan;149(1):99-108. doi: 10.1007/s10549-014-3236-8. Epub 2014 Dec 18. Breast Cancer Res Treat. 2015. PMID: 25519042 Free PMC article.

7

2-Deoxy-Glucose Downregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation, Induction of Endoplasmic Reticulum Stress, and GSK3β Activation.

Kovács K, Decatur C, Toro M, Pham DG, Liu H, Jing Y, Murray TG, Lampidis TJ, Merchan JR. Kovács K, et al. Among authors: merchan jr. Mol Cancer Ther. 2016 Feb;15(2):264-75. doi: 10.1158/1535-7163.MCT-14-0315. Epub 2015 Dec 4. Mol Cancer Ther. 2016. PMID: 26637370 Free PMC article.

8

A Phase I Clinical, Pharmacokinetic, and Pharmacodynamic Study of Weekly or Every Three Week Ixabepilone and Daily Sunitinib in Patients with Advanced Solid Tumors.

Montero AJ, Kwon D, Flores A, Kovacs K, Trent JC, Benedetto P, Rocha-Lima C, Merchan JR. Montero AJ, et al. Among authors: merchan jr. Clin Cancer Res. 2016 Jul 1;22(13):3209-17. doi: 10.1158/1078-0432.CCR-15-2184. Epub 2016 Feb 10. Clin Cancer Res. 2016. PMID: 26864210 Free PMC article. Clinical Trial.

9

In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses.

Jing Y, Chavez V, Khatwani N, Ban Y, Espejo AP, Chen X, Merchan JR. Jing Y, et al. Cancer Gene Ther. 2020 Dec;27(12):910-922. doi: 10.1038/s41417-020-0171-1. Epub 2020 Mar 31. Cancer Gene Ther. 2020. PMID: 32231231 Free PMC article.

10

Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.

Merchan JR, Tang J, Hu G, Lin Y, Mutter W, Tong C, Karumanchi SA, Russell SJ, Sukhatme VP. Merchan JR, et al. J Natl Cancer Inst. 2006 Jun 7;98(11):756-64. doi: 10.1093/jnci/djj208. J Natl Cancer Inst. 2006. PMID: 16757700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page